Alnylam Announces Plan to Initiate Rolling Submission of a New Drug Application Pharmaceutical Investing
Isodiol International Inc. Announces Plans to Enter Pet Industry with All-Natural CBD Supplement Line Cannabis Investing News
PreveCeutical to Visit Penta 5 Group’s Packaging Facility for Due Diligence on Proposed Acquisition Biotech Investing
Iovance Biotherapeutics Announces Pricing of Its Public Offering of Approximately $220 Million of Common Stock Pharmaceutical Investing
Life Science Big News Roundup: Chemesis International Inc. & Rapid Dose Therapeutics Sign a Definitive Agreement; Therma Bright Engages Top Virology Research Group to Conduct Further Tests of TherOZap(TM) Technology; BriaCell Initiates Dosing in Phase I/IIa Combination Study with KEYTRUDA® or YERVOY® Life Science Investing
Q BioMed is Moving Towards Clinical Trials for Autistic Spectrum Disorder Drug Program Biotech Investing
Therma Bright Engages Top Virology Research Group to Conduct Further Tests of TherOZap(TM) Technology Against the Zika Virus Biotech Investing
